Publications Database

Aman M. G. et al. (2005)

Acute and long-term safety and tolerability of risperidone in children with autism.

Journal of Child and Adolescent Psychopharmacology

15(6), pp. 869-884

Read Abstract (New Window)

Aman M. G. et al. (2008)

Cognitive effects of risperidone in children with autism and irritable behavior.

Journal of Child and Adolescent Psychopharmacology

18(3), pp. 227-236

Read Abstract (New Window) Read Full (New Window)

Aman M. G. et al. (2015)

Tolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trial.

Journal of Child and Adolescent Psychopharmacology

August, 25(6), pp. 482-493.

Read Abstract (New Window) Read Full (New Window)

Anderson G. M. et al. (2007)

Effects of short- and long-term risperidone treatment on prolactin levels in children with autism.

February, 61(4), pp. 545-550.

Read Abstract (New Window)

Aneja A. , Tierney E. (2008)

Autism: the role of cholesterol in treatment

International Review of Psychiatry

April, 20(2), pp. 165-170

Read Abstract (New Window)

Arnold L. E. et al. (2000)

Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network.

Journal of Autism and Developmental Disorders

April, 30(2), pp. 99–111

Read Abstract (New Window)

Carroll D. et al. (2014)

Examination of aggression and self injury in children with autism spectrum disorders and serious behavioral problems.

Child and Adolescent Psychiatric Clinics of North America

January, 23(1), pp. 57-72.

Read Abstract (New Window)

Jahromi L. B. et al. (2009)

Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity.

Journal of Autism and Developmental Disorders

39(3), pp. 395-404

Read Abstract (New Window)

Lindsay R. L. et al. (2006)

Dietary status and impact of risperidone on nutritional balance in children with autism: A pilot study.

Journal of Intellectual and Developmental Disability

December, 31(4), pp. 204-209.

Read Abstract (New Window)

Martin A. et al. (2004)

Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.

American Journal of Psychiatry

161(6), pp. 1125-1127

Read Abstract (New Window) Read Full (New Window)

McCracken J. T. et al. (2014)

Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders.

Pharmacogenomics

14(3), pp. 295-302.

Read Abstract (New Window) Read Full (New Window)

McDougle C. J. et al. (2000)

Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.

Child and Adolescent Psychiatric Clinics of North America

January, 9(1), pp. 201-224.

Read Abstract (New Window)

McDougle C. J. et al. (2005)

Risperidone for the core symptom domains of autism: results from the study by the Autism Network of the Research Units on Pediatric Psychopharmacology.

American Journal of Psychiatry

162(6), pp. 1142-1148

Read Abstract (New Window) Read Full (New Window)

Nikolov R. N. et al. (2009)

Gastrointestinal symptoms in a sample of children with pervasive developmental disorders.

Journal of Autism and Developmental Disorders

39(3), pp. 405-413

Read Abstract (New Window)

Posey D. J. et al. (2007)

Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.

Biological Psychiatry

61(4), pp. 538-544.

Read Full (New Window)

Scahill L. et al. (2006)

A prospective open trial of guanfacine in children with pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

16(5), pp. 589-598.

Read Abstract (New Window) Read Full (New Window)

Scahill L. et al. (2001)

Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism.

Journal of Child and Adolescent Psychopharmacology

11(4), pp. 377-388

Read Abstract (New Window)

Scahill L. et al. (2001)

Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism.

Journal of Child and Adolescent Psychopharmacology

Winter, 11(4), pp, 377-88.

Read Abstract (New Window)

Scahill L. et al. (2017)

Using a patient-centered outcome measure to test methylphenidate versus placebo in children with autism spectrum disorder.

Journal of Child and Adolescent Psychopharmacology

March, 27(2), pp. 125-131.

Read Abstract (New Window) Read Full (New Window)

Tierney E. et al. (2007)

Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study.

Psychopharmacology (Berl)

March, 191(1), pp. 149-157.

Read Abstract (New Window)